A detailed history of Northern Trust Corp transactions in Entera Bio Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 200,745 shares of ENTX stock, worth $379,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200,745
Previous 198,831 0.96%
Holding current value
$379,408
Previous $338,000 12.72%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$1.6 - $2.36 $3,062 - $4,517
1,914 Added 0.96%
200,745 $381,000
Q1 2025

May 13, 2025

SELL
$1.7 - $2.72 $23,208 - $37,133
-13,652 Reduced 6.42%
198,831 $338,000
Q4 2024

Feb 14, 2025

BUY
$1.54 - $2.26 $327,223 - $480,211
212,483 New
212,483 $441,000

Others Institutions Holding ENTX

About Entera Bio Ltd.


  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $54.5M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.